EP3570885
Aðferð til að meðhöndla eða bæta efnaskiptaraskanir með því að nota GLP-1 viðtaka-örva sem eru samtengdir við mótlyf fyrir maga-hindrunar peptíð-viðtaka (GIPR)
:
EP einkaleyfi í gildi á Íslandi:
16.1.2018:
18.9.2024:
18714635.2
:
11.12.2024:
15.1.2025
:
15.1.2038:
15.1.2026:
31.1.2026
:
METHOD OF TREATING OR AMELIORATING METABOLIC DISORDERS USING GLP-1 RECEPTOR AGONISTS CONJUGATED TO ANTAGONISTS FOR GASTRIC INHIBITORY PEPTIDE RECEPTOR (GIPR)
16.1.2018
18.9.2024
11.12.2024
15.1.2025
15.1.2026
:
Amgen Inc.:
One Amgen Center Drive Thousand Oaks, California 91320, US
:
CHENG, Yuan:
Newbury Park, California 91320, US
:
NETIROJJANAKUL, Chawita:
Sherman Oaks, California 91403, US
:
HOLDER, Jerry Ryan:
Simi Valley, California 93065, US
:
WU, Bin:
Thousand Oaks, California 91362, US
:
FALSEY, James R.:
Moorpark, California 93021, US
:
HERBERICH, Bradley J.:
Newbury Park, California 91320, US
:
SHAM, Kelvin:
Thousand Oaks, California 91362, US
:
MIRANDA, Leslie P.:
Thousand Oaks, California 91362, US
:
LU, Shu-Chen:
Thousand Oaks, California 91362, US
:
VENIANT-ELLISON, Murielle M.:
Thousand Oaks, California 91360, US
:
STANISLAUS, Shanaka:
Thousand Oaks, California 91360, US
:
YIE, Junming:
Warren, New Jersey 07059, US
:
XU, Jing:
Waltham, Massachusetts 02452, US
:
Árnason Faktor ehf.:
Guðríðarstíg 2-4, 113, Reykjavík,
:
201762447332 P:
17.1.2017:
US
:
US2018013918:
16.1.2018
:
A61K 39/395, C07K 16/28, A61P 3/10
: 8
: 20.1.2025
: 15.1.2026
: Árnason Faktor ehf.